The Russell 2000 Index was up 0.41% over the past day, followed by the S&P 500 ([SPX]) at 0.28% and the Dow Jones Industrial average ([.DJIA]) at 0.19%
With Healthcare holding the top spot in our DALI sector rankings, the sector continues to demonstrate strong relative strength across multiple time frames. Healthcare and Biotechnology both rank among the top five groups on the Asset Class Group Scores page, reflecting leadership on both a long-term and short-term basis.
The ten week for the S&P 500 ([^TWSPX]) has continued to tick higher and now maintains a chart level of 60%, signaling a continual increase in near-term participation. Meanwhile, the percent positive for the S&P 500 ([^PTSPX]) still remains in a column of Os with a current chart level below 50%, demonstrating long-term weakness.
On the earnings front, a few major companies are expected to report earnings over the next week: Apple Inc. ([AAPL] 5/5 TA Score on 11/02), Advanced Micro Devices, Inc. ([AMD] 4/5 TA Score on 11/03), and AbbVie ([ABBV] 5/5 TA on 10/30).
Yesterday’s research highlighted several key relative strength reversals that emerged in October, suggesting market leadership may be broadening beyond cap-weighted growth stocks. While growth remains the long-term leader, these shifts could signal an expanding opportunity set across other areas of the market.